Document is current
Any future updates will be listed below
-
Authors
Giubilaro, Jenna https://orcid.org/0000-0003-2746-5134
Schuetz, Doris A. https://orcid.org/0000-0001-8615-9554
Stepniewski, Tomasz M.
Namkung, Yoon https://orcid.org/0000-0002-3085-2066
Khoury, Etienne
Lara-Márquez, Mónica
Campbell, Shirley
Beautrait, Alexandre
Armando, Sylvain
Radresa, Olivier
Duchaine, Jean
Lamarche-Vane, Nathalie https://orcid.org/0000-0002-9540-3157
Claing, Audrey
Selent, Jana
Bouvier, Michel https://orcid.org/0000-0003-1128-0100
Marinier, Anne https://orcid.org/0000-0002-0116-8345
Laporte, Stéphane A. https://orcid.org/0000-0002-0633-543X
- License Information
-
More Information
Article History
Received: 5 August 2020
Accepted: 17 July 2021
First Online: 3 August 2021
Competing interests
: Some of the BRET-based biosensors used in the present study are licenced to Domain Therapeutics for commercial use. The biosensors are freely available under material transfer agreement for academic research and can be requested from S.A.L. (stephane.laporte@mcgill.ca) or M.B. (michel.bouvier@umontreal.ca). M.B. is the president of the Domain Therapeutics Scientific Advisory Board. All other authors declare no competing interests.
